Angiogenesis Assays A Critical Appraisal of Current Techniques
, by Staton, Carolyn A.; Lewis, Claire; Bicknell, Roy- ISBN: 9780470016008 | 0470016000
- Cover: Hardcover
- Copyright: 2/5/2007
Professor Claire Lewis. Professor of Molecular & Cellular Pathology, Academic Unit of Pathology, University of Sheffield Medical School.
Professor Roy Bicknell. CRUK Molecular Angiogenesis Labs, Institute of Molecular Medicine, University of Oxford.
Foreword | p. xi |
Preface | p. xv |
List of contributors | p. xvii |
Endothelial cell biology | p. 1 |
Abstract | p. 1 |
Introduction | p. 1 |
Morphology of the endothelium | p. 2 |
Endothelial cell adhesion and interactions | p. 4 |
Coagulation and haemostasis | p. 21 |
Transport | p. 13 |
Angiogenesis | p. 14 |
Isolation and culture of endothelial cells | p. 19 |
Endothelial cell heterogeneity and organ specificity | p. 21 |
Gene expression in endothelial cells | p. 23 |
Conclusions | p. 28 |
References | p. 28 |
Endothelial cell proliferation assays | p. 39 |
Abstract | p. 39 |
Introduction | p. 39 |
Cell proliferation | p. 41 |
Cell proliferation assays | p. 42 |
Conclusions | p. 48 |
References | p. 49 |
Endothelial cell migration assays | p. 51 |
Abstract | p. 51 |
Introduction | p. 51 |
Transfilter assay | p. 52 |
'Wound healing' assay | p. 55 |
Teflon fence assay | p. 57 |
Phagokinetic track assay | p. 58 |
In/ex vivo approaches for studying endothelial cell migration | p. 59 |
Conclusions | p. 60 |
References | p. 60 |
Tubule formation assays | p. 65 |
Abstract | p. 65 |
Introduction | p. 65 |
Endothelial cell sources | p. 66 |
Endothelial cell morphology and tubule formation | p. 67 |
Tubule assay matrices | p. 68 |
2D assay protocols | p. 69 |
Analysis of tubule formation in 2D assays | p. 73 |
Recent developments in 2D assays | p. 77 |
3D assays | p. 78 |
Analysis of 3D assays | p. 79 |
Co-culture assays | p. 80 |
Conclusions | p. 82 |
References | p. 82 |
Modelling the effects of the haemodynamic environment on endothelial cell responses relevant to angiogenesis | p. 89 |
Abstract | p. 89 |
Introduction | p. 89 |
Definitions | p. 91 |
Experimental patterns of shear exposure and relevance to angiogenesis assays | p. 93 |
Methods for studying responses of endothelial cells exposed to shear stress | p. 94 |
Readouts in flow cultures relevant to angiogenesis | p. 98 |
Critical considerations and conclusions | p. 99 |
References | p. 101 |
Whole or partial vessel outgrowth assays | p. 105 |
Abstract | p. 105 |
Introduction | p. 105 |
Rat aortic ring assay | p. 106 |
Mouse aorta models | p. 108 |
Chick aortic arch assay | p. 109 |
Porcine carotid artery assay | p. 110 |
Human explant cultures | p. 110 |
Recent developments | p. 112 |
Quantification | p. 113 |
Strengths and weaknesses of organ culture assays | p. 115 |
Applications | p. 117 |
Conclusions | p. 118 |
References | p. 118 |
Assaying endothelial-mural cell interactions | p. 123 |
Abstract | p. 123 |
2D models to study endothelial-mural cell interactions | p. 123 |
3D models to study blood vessel assembly | p. 128 |
Summary | p. 134 |
References | p. 135 |
Assays for membrane and intracellular signalling events | p. 139 |
Abstract | p. 139 |
Introduction | p. 139 |
The endothelial caveolae as the organizers of efficient spatial signal transduction mechanisms | p. 140 |
The prostaglandins forming system: regulation of signal transduction and angiogenesis | p. 141 |
Use of antisense oligo and siRNA to evaluate the function of single signalling molecules | p. 143 |
Knocking down and knocking out Caveolin-1 gene | p. 151 |
Analysing protein-protein interactions in signalling molecules involved in angiogenesis | p. 152 |
Final remarks | p. 155 |
References | p. 157 |
Implantation of sponges and polymers | p. 167 |
Abstract | p. 167 |
Introduction | p. 167 |
Materials used in implantation techniques | p. 169 |
Implantation technique for assessment of inflammatory processes | p. 170 |
Implantation technique for assessment of systemic pathological conditions | p. 170 |
Implantation technique for assessment of tumour angiogenesis | p. 171 |
Implantation technique for assessment of inflammatory angiogenesis in genetically modified mice | p. 172 |
Applications of cannulated sponge model for testing angiogenesis modulators | p. 172 |
Techniques for assessment of the vascularization in implants | p. 172 |
Summary of cannulated sponge assay: advantages and disadvantages | p. 178 |
References | p. 179 |
Angiogenesis assays in the chick | p. 183 |
Abstract | p. 183 |
Introduction | p. 183 |
Overview of the basic 'in shell' CAM assay | p. 186 |
Variations on the CAM assay | p. 189 |
Summary of the CAM assay: disadvantages and advantages | p. 199 |
References | p. 200 |
Corneal angiogenesis assay | p. 203 |
Abstract | p. 203 |
Introduction | p. 203 |
Anatomy and histology | p. 204 |
Brief history of CNV assays | p. 205 |
The process of corneal neovascularization | p. 206 |
Experimental induction of corneal neovascularization | p. 208 |
Discussion and conclusions | p. 220 |
References | p. 222 |
Dorsal air sac model | p. 229 |
Abstract | p. 229 |
Introduction | p. 229 |
Preparation of the DAS model | p. 230 |
Evaluation of anti-angiogenic photodynamic therapy using a DAS model | p. 231 |
Determination of blood volume or blood flow in the angiogenic site using the DAS model | p. 232 |
Quantitative or semi-quantitative analysis of angiogenesis in the DAS model | p. 234 |
Isolation and application of neovessel-targeting probe using DAS model | p. 236 |
Conclusions | p. 237 |
References | p. 237 |
Chamber assays | p. 239 |
Abstract | p. 239 |
Introduction | p. 239 |
In vivo imaging of angiogenesis and microcirculation | p. 240 |
Chamber assays | p. 241 |
Physiological angiogenesis | p. 246 |
Tumour angiogenesis | p. 248 |
Angiogenesis in endometriosis | p. 249 |
Angiogenesis in wound and bone healing | p. 250 |
Angiogenesis in ischaemia and hypoxia | p. 252 |
Angiogenesis in transplantation | p. 252 |
Angiogenesis in biomaterial incorporation | p. 254 |
Angiogenesis in tissue engineering | p. 255 |
Conclusions and perspectives | p. 256 |
References | p. 257 |
Tumour models: analysis of angiogenesis in vivo | p. 265 |
Abstract | p. 265 |
Introduction | p. 265 |
Tumour microenvironment and angiogenesis | p. 266 |
Tumour models | p. 267 |
Subcutaneous tumour models | p. 271 |
Orthotopic tumour models | p. 272 |
Transgenic mouse models of tumour angiogenesis | p. 277 |
Monitoring vascular permeability | p. 279 |
Analysis of angiogenesis in tumours | p. 280 |
Conclusions | p. 283 |
References | p. 283 |
Angiomouse: imageable models of angiogenesis | p. 293 |
Abstract | p. 293 |
Introduction | p. 293 |
Fluorescent proteins to image angiogenesis | p. 294 |
Dual-colour tumour host models | p. 297 |
ND-GFP mouse model | p. 300 |
Methods of angiogenesis analysis in GFP models | p. 306 |
Conclusions | p. 307 |
References | p. 308 |
Techniques and advances in vascular imaging in Danio rerio | p. 311 |
Abstract | p. 311 |
Introduction | p. 311 |
Visualizing the developing vasculature | p. 312 |
In situ hybridization reveals vascular specific expression | p. 318 |
Vascular specific fluorescent reporter lines | p. 320 |
Chemical mutagenesis screens reveal novel genes involved in cardiovascular development | p. 321 |
Conclusions | p. 323 |
References | p. 324 |
Biological and clinical implications of recruitment of stem cells into angiogenesis | p. 327 |
Abstract | p. 327 |
Introduction | p. 327 |
Phenotypic and functional characterization of EPCS | p. 328 |
Mobilization, homing and differentiation of EPCS | p. 332 |
Ageing | p. 335 |
Therapeutic applications | p. 335 |
Conclusions | p. 337 |
References | p. 337 |
Methods for monitoring of the anti-angiogenic activity of agents in patients: novel trial design | p. 341 |
Abstract | p. 341 |
Introduction | p. 341 |
Tumour micro-environmental factors | p. 343 |
Possible mechanisms of acquired resistance to anti-angiogenic drugs | p. 348 |
Standard chemotherapy versus angiogenesis inhibitors | p. 348 |
Monitoring clinical trials | p. 349 |
Tumour dormancy and tumour progression | p. 350 |
Tumour markers | p. 351 |
Microvessel density | p. 351 |
Surrogate endpoints | p. 352 |
Molecular imaging | p. 354 |
New insights into trial design | p. 354 |
Concluding remarks | p. 355 |
References | p. 355 |
An overview of current angiogenesis assays: Choice of assay, precautions in interpretation, future requirements and directions | p. 361 |
Abstract | p. 361 |
Introduction | p. 361 |
In vitro assays | p. 362 |
In vivo assays | p. 365 |
Clinical trials | p. 370 |
Future directions | p. 370 |
Concluding comments | p. 371 |
References | p. 372 |
Index | p. 375 |
Table of Contents provided by Ingram. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.
Digital License
You are licensing a digital product for a set duration. Durations are set forth in the product description, with "Lifetime" typically meaning five (5) years of online access and permanent download to a supported device. All licenses are non-transferable.
More details can be found here.